Heartworm Prevention (Unknown)

Verify with FDA CVM →

969 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
969
Total Reports
27
Deaths Reported
280.0%
Death Rate

Active Ingredients

Heartworm Prevention (Unknown)

Administration Routes

UnknownOralTopical

Species Affected

Dog 960
Cat 8
Unknown 1

Most Affected Breeds

Retriever - Labrador 96
Chihuahua 55
Crossbred Canine/dog 49
Terrier - Yorkshire 45
Shih Tzu 44
Shepherd Dog - German 40
Retriever - Golden 32
Pit Bull 32
Maltese 29
Boxer (German Boxer) 22

Most Reported Reactions

Emesis 232
Lack of efficacy (ectoparasite) - flea 160
Vomiting 141
Lack of efficacy (endoparasite) - heartworm 133
Lethargy (see also Central nervous system depression in 'Neurological') 104
Lack of efficacy - NOS 53
Diarrhoea 40
Other abnormal test result NOS 33
Behavioural disorder NOS 32
Decreased appetite 26
Seizure NOS 26
Lack of efficacy (flea) 22

Outcome Breakdown

Outcome Unknown
411 (42.5%)
Recovered/Normal
400 (41.3%)
Ongoing
73 (7.5%)
Recovered with Sequela
57 (5.9%)
Died
22 (2.3%)
Euthanized
5 (0.5%)

Data Summary

Metric Value
Total adverse event reports 969
Reports involving death 27
Case-fatality rate (reported events) 280.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Heartworm Prevention (Unknown) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 969 adverse event reports referencing Heartworm Prevention (Unknown), including 27 reports in which the animal died — a 280.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Heartworm Prevention (Unknown). Reported administration routes include Unknown, Oral, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Heartworm Prevention (Unknown) reports are Dog (960 reports), Cat (8 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (96), Chihuahua (55), Crossbred Canine/dog (49) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Heartworm Prevention (Unknown) are Emesis (232), Lack of efficacy (ectoparasite) - flea (160), Vomiting (141), Lack of efficacy (endoparasite) - heartworm (133). Of the 968 reports with a coded outcome, Outcome Unknown is the leading category at 42.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Heartworm Prevention (Unknown).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial